← Back to headlines
BMO Capital Cuts Price Target on BioNTech SE (BNTX)
BMO Capital has reduced its price target for BioNTech SE (BNTX) from $143 to $128.
31 Mar, 15:06 — 31 Mar, 15:06
Sources
Showing 1 of 1 sources
Related Stories
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
49m ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
59m ago
North Macedonia Reports New West Nile Virus Fatality Amid Enhanced Surveillance
1h ago
Germany Reports Record 15,800 Heat-Related Deaths This Summer
2h ago